This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Inclusion Criteria: Subjects with a known diagnosis of type 2 diabetes -
Exclusion Criteria: None, except known intolerance to n-acetylcysteine
-